Will the Rituximab Revolution help end the CDC cover-up of America's biggest epidemic?

The Rituximab Revoltuion may be a nightmare for the Centers for Disease Control as it makes the public aware of the following issues:

The Rituximab Revolution may make millions of people aware that they need serious chemotherapy with all kinds of possible side effect for a disease he CDC has covered up for three decades.

The Rituximab Revolution may make millions of people aware that Chronic Fatigue Syndrome really is a form of AIDS. (Judy Mikovits has called it "HIV-negative AIDS.)

The Rituximab Revolution could make the public also relize that everything the CDC has told the public about AIDS is fraud and bullshit.

The Rituximab Revolution may make it clear that we are in the middle of a HHV-6/7/8 epidemic.

Keep up with the Rituximab Revolution at 

Rituximab University

Background on Rituximab

From Wikipedia, the free encyclopedia

Rituximab (trade names Rituxan, MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.

 https://en.wikipedia.org/wiki/Rituximab

Does Rituximab show AIDS and Chronic Fatigue syndrome are one intertwined epidemic?

 Is the cover-up of the link between AIDS and Chronic Fatigue Syndrome coming to an end?

Adding rituximab to chemotherapy regimens improves outcomes for AIDS-related lymphomas

 http://www.aidsmap.com/Adding-rituximab-to-chemotherapy-regimens-improves-outcomes-for-AIDS-related-lymphomas/page/2173050/

 

 Cort Johnson:More is Better: Rituximab Trial Boosts Hopes for Chronic Fatigue Syndrome
http://simmaronresearch.com/2015/07/more-is-better-rituximab-trial-boosts-hopes-for-chronic-fatigue-syndrome/

 

The case for rituximab in AIDS-related lymphoma

 http://simmaronresearch.com/2015/07/more-is-better-rituximab-trial-boosts-hopes-for-chronic-fatigue-syndrome/

Rituximab and Chronic Fatigue Syndrome

A new study from Norway suggests that rituximab (together with methotrexate) might help patients with chronic fatigue syndrome.[17] A clinical trial is ongoing.

HHV-6 and B-cells

---

Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.

L Flamand, I Stefanescu, D V Ablashi, and J Menezes
J Virol. 1993 November; 67(11): 6768–6777
"Interestingly, human B-cells appear to be particularly susceptible to HHV-6 infection in vitro only if they have been previously infected with EBV." http://www.ncbi.nlm.nih.gov/pmc/articles/PMC238118/?page=1
"The detection of HHV-6 genomic sequences in some B-cell neoplasias and the potential of an HHV-6 genomic segment in transforming rodent cells suggests a possible, if indirect, role for the virus in certain cancers."
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC238118/?page=2
"It can tentatively be hypothesized that HHV-6 activates EBV in B-cells by inducing the immediate-early transactivator, Zebra." http://www.ncbi.nlm.nih.gov/pmc/articles/PMC238118/?page=7
"By inducing EBV, HHV-6 may, therefore, contribute to the increase of the B-cell pool infected with EBV, thereby increasing the chances of developing an EBV-related lymphoma. Taken together the present study illustrates the inteactions between two viruses, both belonging to the same family, which can infect B lymphocytes."
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC238118/?page=8
"We have demonstrated that infection of EBV genome-positive cells by HHV-6 leads to reactivation of EBV."
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC238118/?page=8

More is Better: Rituximab Trial Boosts Hopes for Chronic Fatigue Syndrome

- See more at: http://simmaronresearch.com/2015/07/more-is-better-rituximab-trial-boosts-hopes-for-chronic-fatigue-syndrome/#sthash.vqELgvAR.dpuf